TLSI
TriSalus Life Sciences Inc.
4.30$
+4.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
TriSalus Life Sciences Inc. (TLSI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.2 | -0.5 | -0.4 | -0.7 | -11 | -8.1 | -23 | -8.3 | -11 | -9.2 | -22 | -8.8 | -11 | -13 | -11 | -5.7 | -4.5 | -7.3 | -3.7 | -2.5 | -6.5 | -17 | -29 | |
| – | – | – | 0.2 | 0.3 | 0.0 | 0.5 | -0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.7 | |
| – | – | – | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 1.0 | 1.1 | 1.3 | 1.4 | 1.7 | 1.6 | 1.9 | 3.4 | 2.2 | 2.5 | 5.1 | 13 | |
| 0.1 | 0.3 | 0.4 | 0.5 | -3.0 | 0.2 | -1.0 | 3.4 | -0.7 | 2.0 | -4.6 | 4.0 | -0.5 | -6.4 | -3.2 | 0.5 | 1.6 | -1.4 | 2.4 | -0.5 | 0.3 | -2.2 | -0.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 0.5 | 0.3 | 0.1 | 0.0 | 0.2 | 0.7 | 0.1 | 0.1 | 0.2 | 0.1 | 0.8 | 0.1 | 0.2 | 0.0 | 0.1 | 0.2 | 0.6 | |
| – | – | -250 | 0.1 | -0.4 | 0.0 | -1.6 | -0.3 | -0.1 | 0.0 | -1.1 | -0.7 | -0.1 | -0.1 | -0.2 | – | -0.7 | 0.1 | -0.2 | 0.0 | -0.1 | -0.2 | -0.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -232 | – | -8.5 | 8.5 | 0.0 | – | – | – | – | – | – | – | 0.4 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 9.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 252 | 0.5 | 0.1 | 3.5 | 6.7 | 5.9 | 7.9 | 6.4 | 40 | 0.0 | 3.1 | 26 | 5.8 | 3.0 | 9.7 | 21 | 0.1 | 0.3 | 42 | 42 | 85 | |
| 1.1 | -0.5 | -0.4 | -0.1 | -11 | -4.6 | 0.1 | -2.7 | -2.6 | -2.9 | 21 | -9.5 | -7.8 | 13 | -5.2 | -2.8 | 4.5 | 13 | -3.8 | -2.2 | 36 | 25 | 56 | |
| -0.2 | -0.5 | -0.4 | -0.7 | -11 | -8.2 | -23 | -8.6 | -11 | -9.3 | -22 | -9.5 | -11 | -13 | -11 | -5.8 | -5.3 | -7.2 | -3.9 | -2.5 | -6.6 | -17 | -30 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.